x
 
Close

The Future of Nuclear Medicine & PET

Watch the replay of our interactive, open roundtable discussion led by LANDAUER Practice Associates Ken Repking and Christine Krieman as we explore the evolving future of Nuclear Medicine and PET. This informal session is designed to spark conversation around where the field has been, where it’s headed, and how departments can prepare for what’s next. From theranostics and cardiac imaging to emerging facility models, we’ll discuss real-world trends and practical considerations shaping the next five years.  

What We’ll Discuss

  • How Nuclear Medicine has evolved: From traditional studies to the rise of PET and PET/CT, including shifts away from legacy isotopes and procedures
  • The growth of theranostics: Current applications like Lutathera® and Pluvicto®, emerging indications, and what expanding use means for programs
  • Cardiac and bone imaging advancements: Sensitivity and specificity improvements, PET’s growing role in CAD, and reimbursement considerations
  • What remains core in Nuclear Medicine today: Ongoing use cases such as HIDA, V/Q and CT V/Q, and GI bleed studies
  • Preparing for the next 5 years: Facility planning, outpatient theranostic models, and the question of how PET and Nuclear Medicine departments may continue to evolve
By checking this box, I agree to receive marketing communications and product offers by email from Fluke, transacting under Fluke Biomedical, RaySafe and LANDAUER, in accordance with its privacy policy.